Fig. 1From: Effect of denosumab switched from bisphosphonates in preventing joint destruction in postmenopausal rheumatoid arthritis patients with anti-cyclic citrullinated peptide antibodiesComparison of the modified Sharp scores at baseline, 12 months, and 24 months. a Modified total Sharp score (0–448). b Modified Sharp erosion score (0–280). c Modified Sharp joint space narrowing score (0–168). Results are expressed as the mean and standard deviationBack to article page